About this study
This study aims to determine whether long-term methamphetamine use produces changes to driving ability, and if this can be effectively measured and monitored by tracking eye-movements during driving. This will be compared to people who have not had any lifetime history of amphetamine substance usage.
You may be eligible to participate if you:
- are a male or female aged 21 to 60 years
- are willing and able to provide written informed consent
- understand and are willing and able to comply with all study procedures
- are fluent in written and spoken English
- have normal vision or corrected with contact lenses
- have normal cognitive function
- currently hold a (full) driver's licence (no ‘P platers’) and are active drivers (at least once per week) with at least three years of driving experience
- have no lifetime history of illicit amphetamine substance usage [amphetamine, methamphetamine, methylenedioxymethamphetamine (MDMA)]
- have not used other illicit substances or consumed prescription medications recreationally (those not prescribed to you) in past 12 months.
You will be asked to first complete a comprehensive pre-screening questionnaire to ensure that you will be eligible to take part before attending a single study session at Swinburne University in Hawthorn, Melbourne. This onsite visit will take approximately four hours.
First, you will be medically screened by the study nurse and be introduced to the driving simulation task and the simulator environment. After these screening procedures, you will complete some questionnaires before completing the first of the cognitive testing tasks and follow up surveys.
After this, you will complete the driving simulator task with simultaneous eye monitoring and completing some driving performance questionnaires. We will then provide you with some lunch before repeating these procedures.
You will be reimbursed for your time and will be provided with lunch on the day.
For further enquiries
Please email Dr Amie Hayley at email@example.com.